首页>投融资
Sterling Pharma Solutions
未透露
Sterling Pharma Solutions Limited provides active pharmaceutical ingredients and formulations. The Company offers contract research and manufacturing, project management, product database, hazard evaluation, and biological treatment services.In March 2022, Sterling Pharma Solutions Ltd announced that it reached agreement with Novartis to acquire its Ringaskiddy campus, near Cork, Ireland.In April 2021, Sterling Pharma Solutions has acquired ADC Biotechnology.In January 2022, Sterling Pharma Solutions commenced a $2.1 million expansion project to increase chemical and analytical capabilities at its facility in Cary, North Carolina
基本信息
-
公司全称Sterling Pharma Solutions
-
类型小分子原料药开发和制造服务提供商
-
产业领域药品研发/制造、原料药
-
公司人数101~500人
-
地址Northumberland,UK Sterling Place,Dudley Cramlington Northumberland NE23; GB; Telephone: 44 (0)191 250 0471;
-
联系电话+4401912500471
-
邮箱
-
成立时间1969-01-01
投融资
-
2023-05-25未公开未透露阿尔卑斯Pantheon Ventures/万神殿GHO Capital
-
2023-05-25未透露未透露GHO CapitalPantheon Ventures/万神殿阿尔卑斯
-
2019-03-14并购未透露GHO Capital
-
2019-03-14收并购未透露GHO Capital
- 加载更多
相关投融资企业
收并购
四川多瑞药业有限公司的艾可宁原料药生产线已顺利通过药品GMP核查，这一认证标志着生产线符合国家药品生产质量管理规范，具备了生产资质和商业化生产能力。随着该生产线全面启动，多瑞医药的原料药业务将进入新的发展阶段。
上市后再融资
This company profile has not been updated since December 2020, when Clene Nanomedicine merged with Tottenham Acquisition I to form Clene.Clene Nanomedicine is a subsidiary of Clene Inc was focused on developing nanotherapeutic medicines for the treatment of bioenergetic failure associated with neurodegenerative diseases. Clene created a novel nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs.In September 2021, Tottenham Acquisition I Limited announced that it has entered into a definitive merger agreement for a business combination with Clene Nanomedicine, Inc.In August 2021, Clene, Inc and Clene Nanomedicine, Inc announced the completion of two lease agreements.In September 2020, Tottenham Acquisition I entered into a definitive merger agreement with Clene Nanomedicine. Tottenham would reincorporate to the state of Delaware by merging with and into Chelsea Worldwide, a Delaware company and wholly owned subsidiary of
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息